Ranitidine and Ankylosing spondylitis - a phase IV clinical study of FDA data

Summary:

Ankylosing spondylitis is reported as a side effect among people who take Ranitidine (ranitidine), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Humira, and have Pain.

The phase IV clinical study analyzes which people have Ankylosing spondylitis when taking Ranitidine. It is created by eHealthMe based on reports of 233,168 people who have side effects when taking Ranitidine from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Ankylosing spondylitis?

Ankylosing spondylitis (type of arthritis affecting the spine) is found to be associated with 739 drugs and 1,051 conditions by eHealthMe. Check the latest studies of Ankylosing spondylitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

233,168 people reported to have side effects when taking Ranitidine.
Among them, 64 people (0.03%) have Ankylosing spondylitis.

Could Ranitidine cause Ankylosing spondylitis?

Among these 64 people:

How long have people been on Ranitidine when they have Ankylosing spondylitis? *

What is the gender of people who have Ankylosing spondylitis when taking Ranitidine? *

female: 55.93 %
male: 44.07 %

What is the age of people who have Ankylosing spondylitis when taking Ranitidine? *

What are other drugs people take besides Ranitidine? *

What are other side effects people have besides Ankylosing spondylitis? *

Drug Ineffective: 24 people, 37.50%
Back Pain: 12 people, 18.75%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 11 people, 17.19%
Depression: 11 people, 17.19%
Pain: 10 people, 15.62%
Nausea (feeling of having an urge to vomit): 9 people, 14.06%
Weakness: 9 people, 14.06%
Intervertebral Disc Degeneration (spinal disc degeneration): 9 people, 14.06%
Joint Pain: 9 people, 14.06%
Pain In Extremity: 8 people, 12.50%

What are the existing conditions these people have? *

Pain: 14 people, 21.88%
High Blood Pressure: 11 people, 17.19%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 9.38%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 9.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 7.81%
Insomnia (sleeplessness): 5 people, 7.81%
High Blood Cholesterol: 5 people, 7.81%
Hypersensitivity: 4 people, 6.25%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 6.25%
Depression: 3 people, 4.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and have Ankylosing spondylitis?

- Check whether Ankylosing spondylitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ranitidine:

Ranitidine (234,475 reports)

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ankylosing spondylitis:

Ankylosing spondylitis (739 drugs)

Browse all the conditions that are associated with Ankylosing spondylitis:

Ankylosing spondylitis (1,051 conditions)

Related publications that referenced our studies

Hung YM, Cheng CC, Wann SR, Lin SL, "Ankylosing spondylitis associated with pulmonary arterial hypertension", Internal Medicine, 2016 Jan .
Hung YM, Cheng CC, Wann SR, Lin SL, "Ankylosing spondylitis associated with pulmonary arterial hypertension", Internal Medicine, 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine (the active ingredients of Ranitidine) and Ranitidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.